Dr. Henry P. Parkman, MD

Dr. Parkman practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Parkman's NPI, 1770501975, was assigned on July 17, 2006. Dr. Parkman graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1982. Dr. Parkman holds Pennsylvania license MD033270E.

Dr. Parkman's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Parkman's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Parkman is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Parkman to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parkman practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Parkman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Parkman is licensed in Pennsylvania.

CMS data shows 819 Medicare services from Dr. Parkman across 16 procedure codes in 2024, for 445 Medicare patients. Medicare paid $51,930 for them.

CMS counts 445 Medicare patients who saw Dr. Parkman in 2024. The largest group is 65 to 74, with 182 patients. 74% of them have high cholesterol, and 73% have high blood pressure. 31% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parkman's median patient age at 58, with 75% women.

In 2024, Dr. Parkman wrote 3,904 Medicare Part D claims for 475 patients. 77% of them were for generic drugs. CMS names the drug for 3,664 of them, across 50 drugs with 11 or more claims each, at $1,809,739 in total drug cost. In 2023, CMS named 3,369 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Parkman for performance year 2024, reported as part of a group. Dr. Parkman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parkman as offering telehealth. CMS counts 102 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Parkman, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 197 papers to Dr. Parkman, published from 2009 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Gastroparesis, Gastric Emptying and Nausea. Dr. Parkman has published most often in Neurogastroenterol Motil. Dr. Parkman's most frequent co-authors are Thomas Lyman Abell, MD, Pankaj J. Pasricha, MD and Gianrico Farrugia, MD.

Dmand AI links Dr. Parkman to 8 clinical trials, 3 of them phase 2 studies. Conditions studied include Gastroparesis, Paralysis and Dyspepsia. Johns Hopkins Bloomberg School of Public Health sponsors the most, 3.

CMS Open Payments shows 38 general payments to Dr. Parkman from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Evoke Pharma, Inc. paid the most, $17,896.

Dr. Parkman graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 1982.